Logo image of KIN2.DE

KINROSS GOLD CORP (KIN2.DE) Stock Fundamental Analysis

FRA:KIN2 - Deutsche Boerse Ag - CA4969024047 - Common Stock - Currency: EUR

10.55  +0.05 (+0.48%)

Fundamental Rating

6

Overall KIN2 gets a fundamental rating of 6 out of 10. We evaluated KIN2 against 40 industry peers in the Metals & Mining industry. Both the health and profitability get an excellent rating, making KIN2 a very profitable company, without any liquidiy or solvency issues. KIN2 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

KIN2 had positive earnings in the past year.
In the past year KIN2 had a positive cash flow from operations.
KIN2 had positive earnings in 4 of the past 5 years.
In the past 5 years KIN2 always reported a positive cash flow from operatings.
KIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFKIN2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

KIN2 has a Return On Assets of 8.73%. This is amongst the best in the industry. KIN2 outperforms 90.00% of its industry peers.
KIN2 has a better Return On Equity (13.83%) than 90.00% of its industry peers.
KIN2 has a Return On Invested Capital of 9.40%. This is amongst the best in the industry. KIN2 outperforms 90.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KIN2 is in line with the industry average of 6.04%.
The 3 year average ROIC (6.22%) for KIN2 is below the current ROIC(9.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROIC 9.4%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.22%
ROIC(5y)6.53%
KIN2.DE Yearly ROA, ROE, ROICKIN2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

With an excellent Profit Margin value of 18.43%, KIN2 belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
In the last couple of years the Profit Margin of KIN2 has declined.
The Operating Margin of KIN2 (28.48%) is better than 92.50% of its industry peers.
In the last couple of years the Operating Margin of KIN2 has grown nicely.
With a decent Gross Margin value of 35.04%, KIN2 is doing good in the industry, outperforming 67.50% of the companies in the same industry.
KIN2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
OM growth 3Y8.95%
OM growth 5Y8.65%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
KIN2.DE Yearly Profit, Operating, Gross MarginsKIN2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

7

2. Health

2.1 Basic Checks

KIN2 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KIN2 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, KIN2 has less shares outstanding
Compared to 1 year ago, KIN2 has an improved debt to assets ratio.
KIN2.DE Yearly Shares OutstandingKIN2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
KIN2.DE Yearly Total Debt VS Total AssetsKIN2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 2.09 indicates that KIN2 is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.09, KIN2 is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
The Debt to FCF ratio of KIN2 is 1.05, which is an excellent value as it means it would take KIN2, only 1.05 years of fcf income to pay off all of its debts.
KIN2's Debt to FCF ratio of 1.05 is amongst the best of the industry. KIN2 outperforms 97.50% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that KIN2 is not too dependend on debt financing.
KIN2 has a better Debt to Equity ratio (0.18) than 72.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Altman-Z 2.09
ROIC/WACC1.03
WACC9.11%
KIN2.DE Yearly LT Debt VS Equity VS FCFKIN2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

KIN2 has a Current Ratio of 2.01. This indicates that KIN2 is financially healthy and has no problem in meeting its short term obligations.
KIN2 has a Current ratio of 2.01. This is in the better half of the industry: KIN2 outperforms 72.50% of its industry peers.
A Quick Ratio of 0.83 indicates that KIN2 may have some problems paying its short term obligations.
KIN2's Quick ratio of 0.83 is in line compared to the rest of the industry. KIN2 outperforms 45.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 0.83
KIN2.DE Yearly Current Assets VS Current LiabilitesKIN2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 54.20% over the past year.
KIN2 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.87% yearly.
The Revenue has grown by 21.44% in the past year. This is a very strong growth!
KIN2 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.04% yearly.
EPS 1Y (TTM)54.2%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%81.82%
Revenue 1Y (TTM)21.44%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%26.9%

3.2 Future

Based on estimates for the next years, KIN2 will show a very negative growth in Earnings Per Share. The EPS will decrease by -25.08% on average per year.
The Revenue is expected to decrease by -9.10% on average over the next years.
EPS Next Y23.46%
EPS Next 2Y14.95%
EPS Next 3Y8.31%
EPS Next 5Y-25.08%
Revenue Next Year7.83%
Revenue Next 2Y3.19%
Revenue Next 3Y2.7%
Revenue Next 5Y-9.1%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
KIN2.DE Yearly Revenue VS EstimatesKIN2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B 5B
KIN2.DE Yearly EPS VS EstimatesKIN2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.75 indicates a correct valuation of KIN2.
Compared to the rest of the industry, the Price/Earnings ratio of KIN2 indicates a somewhat cheap valuation: KIN2 is cheaper than 67.50% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of KIN2 to the average of the S&P500 Index (29.35), we can say KIN2 is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.64, the valuation of KIN2 can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN2 is on the same level as its industry peers.
KIN2's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 16.75
Fwd PE 13.64
KIN2.DE Price Earnings VS Forward Price EarningsKIN2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KIN2 indicates a somewhat cheap valuation: KIN2 is cheaper than 65.00% of the companies listed in the same industry.
KIN2's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KIN2 is cheaper than 92.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.27
EV/EBITDA 5.7
KIN2.DE Per share dataKIN2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

KIN2's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KIN2 has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.71
PEG (5Y)1.13
EPS Next 2Y14.95%
EPS Next 3Y8.31%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.02%, KIN2 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.52, KIN2 is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.33, KIN2's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
KIN2.DE Yearly Dividends per shareKIN2.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.05 0.1 0.15

5.3 Sustainability

15.55% of the earnings are spent on dividend by KIN2. This is a low number and sustainable payout ratio.
DP15.55%
EPS Next 2Y14.95%
EPS Next 3Y8.31%
KIN2.DE Yearly Income VS Free CF VS DividendKIN2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
KIN2.DE Dividend Payout.KIN2.DE Dividend Payout, showing the Payout Ratio.KIN2.DE Dividend Payout.PayoutRetained Earnings

KINROSS GOLD CORP

FRA:KIN2 (3/7/2025, 7:00:00 PM)

10.55

+0.05 (+0.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)05-06 2025-05-06
Inst Owners68.64%
Inst Owner ChangeN/A
Ins Owners0.21%
Ins Owner ChangeN/A
Market Cap12.97B
Analysts80
Price Target13.35 (26.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP15.55%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.21%
Min EPS beat(2)-11.48%
Max EPS beat(2)25.89%
EPS beat(4)3
Avg EPS beat(4)18.32%
Min EPS beat(4)-11.48%
Max EPS beat(4)57.06%
EPS beat(8)7
Avg EPS beat(8)30.18%
EPS beat(12)8
Avg EPS beat(12)13.88%
EPS beat(16)10
Avg EPS beat(16)12.95%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.02%
PT rev (3m)8.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)-11.16%
EPS NY rev (3m)-2.06%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.3%
Revenue NY rev (3m)2.39%
Valuation
Industry RankSector Rank
PE 16.75
Fwd PE 13.64
P/S 2.73
P/FCF 10.27
P/OCF 5.75
P/B 2.05
P/tB 2.05
EV/EBITDA 5.7
EPS(TTM)0.63
EY5.97%
EPS(NY)0.77
Fwd EY7.33%
FCF(TTM)1.03
FCFY9.74%
OCF(TTM)1.83
OCFY17.38%
SpS3.86
BVpS5.14
TBVpS5.14
PEG (NY)0.71
PEG (5Y)1.13
Profitability
Industry RankSector Rank
ROA 8.73%
ROE 13.83%
ROCE 14.95%
ROIC 9.4%
ROICexc 10.02%
ROICexgc 10.02%
OM 28.48%
PM (TTM) 18.43%
GM 35.04%
FCFM 26.63%
ROA(3y)2.29%
ROA(5y)4.25%
ROE(3y)3.43%
ROE(5y)6.8%
ROIC(3y)6.22%
ROIC(5y)6.53%
ROICexc(3y)6.6%
ROICexc(5y)7.07%
ROICexgc(3y)6.6%
ROICexgc(5y)7.13%
ROCE(3y)9.89%
ROCE(5y)10.39%
ROICexcg growth 3Y20.43%
ROICexcg growth 5Y13.37%
ROICexc growth 3Y21.14%
ROICexc growth 5Y13.83%
OM growth 3Y8.95%
OM growth 5Y8.65%
PM growth 3Y45.92%
PM growth 5Y-2.15%
GM growth 3Y3.98%
GM growth 5Y4.42%
F-Score7
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.05
Debt/EBITDA 0.47
Cap/Depr 93.73%
Cap/Sales 20.89%
Interest Coverage 11.44
Cash Conversion 93.6%
Profit Quality 144.49%
Current Ratio 2.01
Quick Ratio 0.83
Altman-Z 2.09
F-Score7
WACC9.11%
ROIC/WACC1.03
Cap/Depr(3y)100.83%
Cap/Depr(5y)104.58%
Cap/Sales(3y)22.97%
Cap/Sales(5y)23.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)54.2%
EPS 3Y17.42%
EPS 5Y14.87%
EPS Q2Q%81.82%
EPS Next Y23.46%
EPS Next 2Y14.95%
EPS Next 3Y8.31%
EPS Next 5Y-25.08%
Revenue 1Y (TTM)21.44%
Revenue growth 3Y11.35%
Revenue growth 5Y8.04%
Sales Q2Q%26.9%
Revenue Next Year7.83%
Revenue Next 2Y3.19%
Revenue Next 3Y2.7%
Revenue Next 5Y-9.1%
EBIT growth 1Y74.49%
EBIT growth 3Y21.31%
EBIT growth 5Y17.39%
EBIT Next Year92.85%
EBIT Next 3Y22.3%
EBIT Next 5Y-6.27%
FCF growth 1Y170.39%
FCF growth 3Y91.05%
FCF growth 5Y62.85%
OCF growth 1Y52.4%
OCF growth 3Y29.17%
OCF growth 5Y14.84%